Maryland Advances Vet Cannabis Bill, Expanding Pet Treatment Options
Maryland legislature unanimously passes bill protecting veterinarians who recommend medical cannabis for animals, awaiting governor's signature.
Maryland's legislature has unanimously approved groundbreaking legislation that would shield veterinarians from legal liability when recommending medical cannabis treatments for animals. The House of Delegates passed the measure 137-0 this week, following a 45-0 Senate approval, sending the bill to Governor Wes Moore's desk for final approval.
The veterinary cannabis protection bill represents a notable expansion of medical marijuana applications beyond human patients, potentially creating new revenue streams for cannabis operators in regulated markets. Pet owners increasingly seek alternative treatments for animal ailments including seizures, chronic pain, and anxiety, driving demand for CBD and THC-based veterinary products that currently operate in regulatory gray areas.
Maryland's move follows similar legislative efforts in states like California, Nevada, and New York, where veterinarians gained legal cover to discuss cannabis treatments with pet owners. The trend signals growing mainstream acceptance of cannabis therapeutics and could accelerate product development in the animal health sector, particularly for companies already manufacturing medical cannabis products.
The unanimous legislative support demonstrates bipartisan recognition of cannabis medical benefits extending beyond human applications. For Maryland's cannabis industry, which launched adult-use sales in July 2023, veterinary recommendations could drive additional medical marijuana card registrations and expand the patient base beyond traditional demographics.
If signed into law, Maryland would join a growing number of states recognizing veterinary cannabis applications, potentially influencing federal policy discussions around cannabis scheduling and veterinary medicine. The legislation's passage reinforces the continuing normalization of cannabis across medical applications, supporting long-term industry growth prospects as regulatory frameworks expand to accommodate diverse therapeutic uses.